Recent News

A mifepristone emergency appeal shows how court-driven health policy turns FDA rules into operational confusion for patients, doctors and pharmacies.

The Pentagon’s AI contracts with major tech firms raise a basic accountability question: who audits classified AI once private platforms become part of military decision loops?

Connecticut’s AI bill shows that the first durable AI rulebook may be written state by state before Washington settles the fight.

CMS tried to improve provider-network transparency, but a Social Security number leak turned the fix into another healthcare trust problem.

The ActBlue-Paxton lawsuit tests whether campaign-finance enforcement can be separated from partisan state power.

Maine’s veto of a first-in-the-nation data-center moratorium shows how AI infrastructure turns into local grid, ratepayer, and development politics.

Reuters says CISA may cut federal vulnerability patching deadlines to three days as AI compresses hacking timelines, raising a bigger question about institutional capacity.

A 5th Circuit ruling blocking mail distribution of mifepristone is also a test of public trust in FDA authority, courts, and health regulation.

The FCC’s expedited review of ABC station licenses shows how administrative power can pressure media without winning a courtroom fight.

An FDA advisory panel voted against AstraZeneca’s experimental breast-cancer drug, showing how evidence standards become public-trust infrastructure.